Yale University

Injection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.

TitleInjection Drug Use and Hepatitis C as Risk Factors for Mortality in HIV-Infected Individuals: The Antiretroviral Therapy Cohort Collaboration.
Publication TypeJournal Article
Year of Publication2015
AuthorsMay, Margaret T., Amy C. Justice, Kate Birnie, Suzanne M. Ingle, Colette Smit, Colette Smith, Didier Neau, Marguerite Guiguet, Carolynne Schwarze-Zander, Santiago Moreno, Jodie L. Guest, Antonella d ľArminio Monforte, Cristina Tural, Michael J. Gill, Andrea Bregenzer, Ole Kirk, Michael Saag, Timothy R. Sterling, Heidi M. Crane, and Jonathan A. C. Sterne
JournalJournal of acquired immune deficiency syndromes (1999)
Volume69
Issue3
Pagination348-54
Date Published2015 Jul 1
ISSN1944-7884
KeywordsAdolescent, Adult, Anti-HIV Agents, CD4 Lymphocyte Count, Cohort Studies, Female, Hepatitis C, HIV Infections, Humans, Male, Middle Aged, Risk Factors, Substance Abuse, Intravenous, Survival Analysis, Treatment Outcome, Viral Load, Young Adult
AbstractHIV-infected individuals with a history of transmission through injection drug use (IDU) have poorer survival than other risk groups. The extent to which higher rates of hepatitis C (HCV) infection in IDU explain survival differences is unclear.
DOI10.1097/QAI.0000000000000603
Alternate JournalJ. Acquir. Immune Defic. Syndr.

External Links